coronavirus January 5, 2024 8:02 am

Study examines effectiveness of main COVID treatment Paxlovid

A new study by researchers at UCSF shows that Paxlovid does not reduce the risk of long COVID, but infectious disease specialist Dr. Peter Chin-Hong said the drug is still effective at preventing severe disease in vulnerable people.

US & World Videos

2:19

San Francisco barbershop struggles to stay open after pandemic
0:51

Alameda County using dogs to detect COVID
3:57

Interview: Doctor's perspective on COVID 4 years after shutdown started
2:27

Marking 4 years since COVID-19 shut down the Bay Area
2:09

CDC updates COVID isolation guidelines
Exit mobile version